Compare · MAMO vs ZBH
MAMO vs ZBH
Side-by-side comparison of Massimo Group (MAMO) and Zimmer Biomet Holdings Inc. (ZBH): market cap, price performance, sector, and recent activity on the wire.
Summary
- MAMO operates in Consumer Discretionary, while ZBH operates in Health Care - the two are in different parts of the market.
- ZBH is the larger of the two at $18.73B, about 424.3x MAMO ($44.1M).
- Over the past year, MAMO is down 61.3% and ZBH is down 4.3% - ZBH leads by 57.0 points.
- ZBH has been more active in the news (8 items in the past 4 weeks vs 1 for MAMO).
- ZBH has more recent analyst coverage (25 ratings vs 0 for MAMO).
- Company
- Massimo Group
- Zimmer Biomet Holdings Inc.
- Price
- $1.08+0.47%
- $98.18-2.42%
- Market cap
- $44.1M
- $18.73B
- 1M return
- +13.68%
- +7.74%
- 1Y return
- -61.29%
- -4.28%
- Industry
- Industrial Specialties
- Industrial Specialties
- Exchange
- NASDAQ
- NYSE
- IPO
- 2024
- News (4w)
- 1
- 8
- Recent ratings
- 0
- 25
Zimmer Biomet Holdings Inc.
Zimmer Biomet Holdings, Inc., together with its subsidiaries, designs, manufactures, and markets musculoskeletal healthcare products and solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company provides orthopaedic reconstructive products, such as knee and hip replacement products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; spine products comprising medical devices and surgical instruments; and face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers dental products that include dental reconstructive implants, and dental prosthetic and regenerative products, as well as surgical, bone cement, and office-based technology products. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, oral surgeons, dentists, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.
Latest MAMO
- SEC Form 10-Q filed by Massimo Group
- Massimo Group filed SEC Form 8-K: Entry into a Material Definitive Agreement, Other Events
- Massimo Group Secures Up to US$4 Million in Controlling Shareholder Funding to Accelerate Intelligent Patrol Systems Development and Terminates Previously Announced FST Acquisition
- Massimo Group Announces Confirmed U.S. Department of Defense and U.S. Army Fleet Orders
- SEC Form 8-K filed by Massimo Group
- Massimo Group Begins Revenue-Generating Fulfillment for Large-Scale Tractor Supply Retail Program
- SEC Form 10-Q filed by Massimo Group
- SEC Form DEF 14A filed by Massimo Group
- Massimo Motor Accelerates Fleet Expansion; Strong Demand for HVAC-Equipped Utility Platforms at NAFA 2026
- Massimo Expands Fleet Network and Advances Second-Generation Autonomous Patrol Platform
Latest ZBH
- Amendment: SEC Form SCHEDULE 13G/A filed by Zimmer Biomet Holdings Inc.
- Zimmer Biomet Holdings Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
- SEC Form 4 filed by President, APAC Desai Chintan
- SEC Form 10-Q filed by Zimmer Biomet Holdings Inc.
- Zimmer Biomet Holdings Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Zimmer Biomet Announces Second Quarter 2026 Financial Results
- Grp Pres-Global Business Thornal Kevin R converted options into 9,957 shares and covered exercise/tax liability with 4,266 shares (SEC Form 4) (tax liability)
- UBS initiated coverage on Zimmer Biomet with a new price target
- SEC Form 3 filed by new insider Desai Chintan
- Zimmer Biomet Names Chintan Desai President of Asia Pacific Region